Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction
β Scribed by Michael D. Lagios; Melvin J. Silverstein
- Book ID
- 106332548
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 25 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Spindle and/or epithelioid melanocytic proliferations that display overlapping histopathologic features of Spitz nevus and Spitzβlike melanoma are diagnostically difficult and controversial melanocytic tumors. There are reports of such lesions metastasizing to regional ly
Axillary lymph node dissection for staging the axilla in breast carcinoma patients is associated with considerable morbidity, such as edema of the arm, pain, sensory disturbances, impairment of arm mobility, and shoulder stiffness. Sentinel lymph node biopsy electively removes the first lymph node,
Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with oc
## Abstract ## BACKGROUND Few data exist regarding techniques, indications, and outcomes for sentinel lymph node biopsy in pediatric patients with sarcomas and carcinomas. ## METHODS A retrospective 10βyear review was conducted, with Institutional Review Board waiver, of the pathology, lymphosci